바로가기메뉴

본문 바로가기 주메뉴 바로가기
 
 

logo

  • ENGLISH
  • P-ISSN1226-6396
  • E-ISSN2234-4942
  • KCI

뇌졸중 후 우울증의 약침치료에 대한 중의학 임상논문 연구동향

Trend Review of Traditional Chinese Medicine Studies on Pharmacopuncture Treatment for Post-Stroke Depression

동의신경정신과학회지 / Journal of Oriental Neuropsychiatry, (P)1226-6396; (E)2234-4942
2021, v.32 no.3, pp.235-245
https://doi.org/10.7231/jon.2021.32.3.235
이여경 (동서한방병원 한방신경정신과)
강현진 (가천대학교 일반대학원 한의학과)
송금주 (동서한방병원 한방신경정신과)
오지연 (동서한방병원 사상체질의학과)
김상범 (동서한방병원 한방신경정신과)
김종민 (동서한방병원 한방신경정신과)
박세진 (동서한방병원 한방신경정신과)

Abstract

Objectives: To provide clinical evidence of pharmacopuncture treatment for post-stroke depression by reviewing randomized controlled trials on Traditional Chinese medicine pharmacopuncture for post-stroke depression. Methods: Randomized controlled trials on pharmacopuncture treatment for post-stroke depression were searched from the China National Knowledge Infrastructure (CNKI). Literature searches of English and Chinese databases were performed. Selected literature was assessed with the Jadad scale. Results: Twelve papers were selected from 20 studies. The following results were obtained: 1) Pharmacopuncture was used for post-stroke depression; 2) Dengzhan-Xixin was the most used injection medicine for post-stroke depression; 3) BaiHui (GV20) was the most used in pharmacopuncture treatment; 4) Based on the Hamilton Depression Rating Scale (HAMD), it was confirmed that all studies using pharmacopunture had significant efficacy. Conclusions: For the treatment of post-stroke depression, Dengzhans-Xixin was commonly used as an injectable medication. Additional research studies on pharmacopuncture including its practical use are needed.

keywords
Post-stroke depression, Traditional Chinese medicine, Pharmacopuncture, Randomized controlled trial, Review

동의신경정신과학회지